Evidence map›Paper›PMID 30334356›Full record

ArticleAmerican journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics2019

DNA methylation of FKBP5 and response to exposure-based psychological therapy.

Susanna Roberts, Robert Keers, Gerome Breen, Jonathan R I Coleman, Peter Jöhren, Agnieszka Kepa, Kathryn J Lester, Jürgen Margraf, Silvia Scheider, Tobias Teismann and 3 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Epigenetic markers of response to psychotherapy in obsessive-compulsive disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. The role of epigenetics in anxiety disorders.Molecular biology reports · 2023
    Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Susanna RobertsKing's College London, Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom.ORCID 0000-0002-2616-2644
Robert KeersKing's College London, Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom.
Gerome BreenKing's College London, Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom.
Jonathan R I ColemanKing's College London, Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom.ORCID 0000-0002-6759-0944
Peter JöhrenDental Clinic Bochum, Bochum, Germany.
Agnieszka KepaKing's College London, Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom.
Kathryn J LesterKing's College London, Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom.
Jürgen MargrafRuhr-Universität Bochum, Mental Health Research and Treatment Center, Bochum, Germany.
Silvia ScheiderRuhr-Universität Bochum, Mental Health Research and Treatment Center, Bochum, Germany.
Tobias TeismannRuhr-Universität Bochum, Mental Health Research and Treatment Center, Bochum, Germany.
André WannemüllerRuhr-Universität Bochum, Mental Health Research and Treatment Center, Bochum, Germany.
Thalia C EleyKing's College London, Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom.
Chloe C Y WongKing's College London, Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom.
King's College London · GBRuhr University Bochum · DENational Health Service · GBQueen Mary University of London · GBUniversity of Sussex · GBZahnklinik Bochum · DE

Funding

Medical Research Council G0901874Medical Research Council MR/J011762/1Medical Research Council MR/K021281/1NIHR Biomedical Research Centre
6 · The paper itself

Abstract

Differential DNA methylation of the hypothalamic-pituitary-adrenal axis related gene FKBP5 has recently been shown to be associated with varying response to environmental influences and may play a role in how well people respond to psychological treatments. Participants (n = 111) received exposure-based cognitive behavioural therapy (CBT) for agoraphobia with or without panic disorder, or specific phobias. Percentage DNA methylation levels were measured for the promoter region and intron 7 of FKBP5. The association between percentage reduction in clinical severity and change in DNA methylation was tested using linear mixed models. The effect of genotype (rs1360780) was tested by the inclusion of an interaction term. The association between change in DNA methylation and FKBP5 expression was examined. Change in percentage DNA methylation at one CpG site of intron 7 was associated with percentage reduction in severity (β = -4.26, p = 3.90 × 10

Indexed as

AdultAgedAgoraphobiaCognitive Behavioral TherapyDNA MethylationEpigenesis, GeneticFemaleGenotypeHumansHypothalamo-Hypophyseal SystemImplosive TherapyIntronsMaleMiddle AgedPituitary-Adrenal SystemPolymorphism, Single NucleotideTacrolimus Binding Protein 5Tacrolimus Binding Proteinsanxietycognitive behavioral therapyepigeneticstreatment response

Identifiers

PMID30334356
PMCPMC6600698
OpenAlexW2809621556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.